Colonoscopy use following mutation detection in Lynch syndrome: Exploring a role for cancer screening in adaptation

Clinical Genetics

Volumn 79, Issue 4, 2011, Pages 321-328

  Hadley, D W ^a   Ashida, S ^a,b   Jenkins, J F ^a   Calzone, K A ^c   Kirsch, I R ^c   Koehly, L M ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Colonoscopy; Genetic testing; Health behavior; HNPCC L ynch syndrome

Indexed keywords

ADAPTATION; ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; COLONOSCOPY; DEPRESSION; EMOTIONAL STRESS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL WELL BEING; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM; SEQUENCE ANALYSIS;

ADAPTATION, PSYCHOLOGICAL; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DEPRESSION; DNA-BINDING PROTEINS; FAMILY HEALTH; FEMALE; GENETIC TESTING; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; QUESTIONNAIRES; YOUNG ADULT;

EID: 79952251574     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01622.x     Document Type: Article

References (28)

1. Lynch HT, Lynch PM, Lanspa SJ et al Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis and medicolegal ramifications. Clin Genet 2009: 76 (1): 1-18.
2. Hampel H, Stephens JA, Pukkala E et al Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005: 129 (2): 415-421.
3. Jenkins MA, Baglietto L, Dowty JG et al Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 2006: 4 (4): 489-498.
4. Vasen HF, Moslein G, Alonso A et al Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007: 44 (6): 353-362.
5. Lindor NM, Petersen GM, Hadley DW et al Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006: 296 (12): 1507-1517.
6. Levin B, Barthel JS, Burt RW et al Colorectal cancer screening clinical practice guidelines. J Natl Compr Cancer Netw 2006: 4 (4): 384-420.
7. deJong AE, Hendriks YM, Kleibeuker JH et al Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006: 130 (3): 665-671.
8. Jarvinen HJ, Aarnio M, Mustonen H et al Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000: 118 (5): 829-834.
9. Hadley DW, Jenkins JF, Dimond E et al Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. Arch Intern Med 2004: 22 (1): 39-44.
10. Hadley DW, Jenkins JF, Steinberg SM et al Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome. J Clin Oncol 2008: 26 (6): 948-954.
11. Claes E, Denayer L, Evers-Kiebooms G et al Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet Test 2005: 9 (1): 54-65.
12. Collins V, Meiser B, Gaff C, St John DJ, Halliday J. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer 2005: 104 (2): 2273-2281.
13. Halbert CH, Lynch H, Lynch J et al Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 2004: 164 (17): 1881-1887.
14. Meiser B, Collins V, Warren R et al Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 2004: 66 (6): 502-511.
15. Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kääriäinen H. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 2001: 93 (4): 608-611.
16. Collins VR, Meiser B, Ukoumunne OC, Gaff C, St John DJ, Halliday JL. The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med 2007: 9 (5): 290-297.
17. Gritz ER, Peterson SK, Vernon SW et al Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005: 23 (9): 1902-1910.
18. Rimes KA, Salkovskis PM, Jones L, Lucassen AM. Applying a cognitive behavioral model of health anxiety in a cancer genetics service. Health Psychol 2006: 25 (2): 171-180.
19. Shiloh S, Koehly L, Jenkins J, Martin J, Hadley D. Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: a longitudinal study. Psychooncology 2008: 17 (8): 746-755.
20. Murakami Y, Okamura H, Sugano K et al Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma. Cancer 2004: 101 (2): 395-403.
21. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ et al Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Educ Couns 2007: 65 (1): 58-68.
22. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003: 21 (12): 2397-2406.
23. Decruyenaere M, Evers-Kiebooms G, Welkenhuysen M, Denayer L, Claes E. Cognitive representations of breast cancer, emotional distress and preventive health behaviour: a theoretical perspective. Psychooncology 2000: 9 (6): 528-536.
24. Hadley DW, Jenkins J, Dimond E et al Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003: 163 (5): 573-582.
25. Radloff LS. The CES-D scale: a self-report depression scale for research in he general population. Appl Psychol Meas 1977: 1: 385-401.
26. Lerman C, Hughes C, Trock BJ et al Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 1999: 281 (17): 1618-1622.
27. Rao K. Recent research in stress, coping and women's health. Curr Opin Psychiatry 2009: 22 (2): 188-193.
28. Shiloh S. Illness representations, self-regulation, and genetic counseling: a theoretical review. J Genet Couns 2006: 15 (5): 325-337.